Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Holding NKTR?
Track your performance easily

Nektar Therapeutics (NKTR) Financial Statements

1,224 Followers

Nektar Therapeutics Financial Overview

Nektar Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.9; its P/E ratio is -1.55; Nektar Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 23.49M$ 21.64M$ 23.89M$ 24.14M$ 20.50M
Gross Profit$ 13.75M$ 13.11M$ 16.60M$ 11.71M$ 13.51M
EBIT$ -52.32M$ -31.31M$ -35.24M$ -45.90M$ -51.17M
EBITDA$ -50.86M$ -29.70M$ -33.59M$ -44.20M$ -49.00M
Net Income Common Stockholders$ -52.36M$ -36.80M$ -42.08M$ -45.84M$ -51.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 271.24M$ 289.24M$ 303.62M$ 372.66M$ 409.43M
Total Assets$ 343.33M$ 396.01M$ 398.03M$ 442.24M$ 494.28M
Total Debt$ 112.10M$ 114.08M$ 117.78M$ 121.29M$ 124.75M
Net Debt$ -159.13M$ -175.16M$ -185.84M$ -251.37M$ -284.68M
Total Liabilities$ 263.65M$ 269.31M$ 267.05M$ 282.88M$ 297.32M
Stockholders Equity$ 79.69M$ 126.70M$ 130.99M$ 159.37M$ 196.96M
Cash Flow-
Free Cash Flow$ -37.89M$ -48.05M$ -47.28M$ -40.91M$ -51.68M
Operating Cash Flow$ -37.70M$ -47.89M$ -47.05M$ -42.12M$ -51.52M
Investing Cash Flow$ 16.98M$ 19.26M$ 17.38M$ 56.41M$ 25.17M
Financing Cash Flow$ 19.00K$ 42.00M$ 12.00K-$ 18.00K
Currency in USD

Nektar Therapeutics Earnings and Revenue History

Nektar Therapeutics Debt to Assets

Nektar Therapeutics Cash Flow

Nektar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis